Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062700

President and COO sold 4,570 shares at an average $16.90 ($77,235)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McNeill Jonathan · President and COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Sale : show line 1 in the form 10b5-1 −731 $17.90 $13,085 138,427 D
2026-09-18 Sale : show line 2 in the form 10b5-1 −3,839 $16.71 $64,150 134,588 D
Open-market sales · 4,570 sh · avg $16.90 · $77,235
Loading xslF345X06/wk-form4_1789761701.xml…